Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-25-006004
Filing Date
2025-01-24
Accepted
2025-01-24 16:17:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 tm253007d5_425.htm 425 18815
2 GRAPHIC tm253007d5_425img001.jpg GRAPHIC 60314
  Complete submission text file 0001104659-25-006004.txt   103624
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filed by) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Subject) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40544 | Film No.: 25554441
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)